Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Evolus, Inc. - Common Stock (NQ:EOLS)

7.860 -0.140 (-1.75%)

Delayed Quote Updated: 2:24 PM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	488,695
Open	7.890
Bid (Size)	7.840 (300)
Ask (Size)	7.860 (200)
Prev. Close	8.000
Today's Range	7.735 - 8.010
52wk Range	3.860 - 9.310
Shares Outstanding	54,576,156
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes

Today 8:30 EDT

From Evolus

Via Business Wire

Evolus Inc (NASDAQ:EOLS) Passes Minervini Trend Template and High Growth Momentum Screen ↗

Today 5:10 EDT

Via Chartmill

Performance

YTD	+17.0%	+17.0%
1 Month	-13.5%	-13.5%
3 Month	+16.6%	+16.6%
6 Month	+82.4%	+82.4%
1 Year	+28.0%	+28.0%

More News

Telix Appoints David Gill as Chair

August 31, 2026

From Telix Pharmaceuticals Limited

Via GlobeNewswire

Evolus Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

Evolus (NASDAQ:EOLS) Tops Q2 EPS Estimates and Raises Revenue Guidance, Shares Gain 5.7% ↗

August 05, 2026

Via Chartmill

Evolus Inc (NASDAQ:EOLS) Q1 2026 Earnings: Narrowed Loss and Positive EBITDA Drive After-Hours Rally ↗

May 04, 2026

Via Chartmill

Evolus Inc (NASDAQ:EOLS) Reports Q4 2025 Earnings Beat and Path to 2026 Profitability ↗

March 03, 2026

Via Chartmill

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

August 05, 2026

From Evolus

Via Business Wire

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

August 04, 2026

From Evolus

Via Business Wire

Evolus to Report Second Quarter Financial Results on August 5, 2026

July 22, 2026

From Evolus

Via Business Wire

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 10, 2026

From Evolus

Via Business Wire

Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

July 08, 2026

From Evolus

Via Business Wire

Evolus to Participate in The Jefferies Global Healthcare Conference

May 19, 2026

From Evolus

Via Business Wire

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

May 11, 2026

From Evolus

Via Business Wire

Evolus (EOLS) Q1 2026 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

Evolus (EOLS) Q2 2025 Earnings Call Transcript ↗

May 04, 2026

Via The Motley Fool

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

May 04, 2026

From Evolus

Via Business Wire

Evolus to Report First Quarter Financial Results on May 4, 2026

April 14, 2026

From Evolus

Via Business Wire

Telix Appoints David Gill as Non-Executive Director

April 01, 2026

From Telix Pharmaceuticals Limited

Via GlobeNewswire

Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference

March 31, 2026

From Evolus

Via Business Wire

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2026

From Evolus

Via Business Wire

Why Evolus Stock Soared Today ↗

March 04, 2026

Via The Motley Fool

What's going on in today's session ↗

March 04, 2026

Via Chartmill

Gapping stocks in Wednesday's session ↗

March 04, 2026

Via Chartmill

Evolus (EOLS) Q4 2025 Earnings Call Transcript ↗

March 03, 2026

Via The Motley Fool

Frequently Asked Questions

Is Evolus, Inc. - Common Stock publicly traded?

Yes, Evolus, Inc. - Common Stock is publicly traded.

What exchange does Evolus, Inc. - Common Stock trade on?

Evolus, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Evolus, Inc. - Common Stock?

The ticker symbol for Evolus, Inc. - Common Stock is EOLS on the Nasdaq Stock Market

What is the current price of Evolus, Inc. - Common Stock?

The current price of Evolus, Inc. - Common Stock is 7.860

When was Evolus, Inc. - Common Stock last traded?

The last trade of Evolus, Inc. - Common Stock was at 10/01/26 02:24 PM ET

What is the market capitalization of Evolus, Inc. - Common Stock?

The market capitalization of Evolus, Inc. - Common Stock is 428.97M

How many shares of Evolus, Inc. - Common Stock are outstanding?

Evolus, Inc. - Common Stock has 429M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.